Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $430.95 million. The enterprise value is $363.38 million.
| Market Cap | 430.95M |
| Enterprise Value | 363.38M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 201.38 million shares outstanding. The number of shares has increased by 265.55% in one year.
| Shares Outstanding | 201.38M |
| Shares Change (YoY) | +265.55% |
| Shares Change (QoQ) | +99.14% |
| Owned by Insiders (%) | 17.19% |
| Owned by Institutions (%) | 69.95% |
| Float | 110.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.44 |
| Forward PS | 41.34 |
| PB Ratio | 8.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.38, with a Debt / Equity ratio of 1.10.
| Current Ratio | 3.38 |
| Quick Ratio | n/a |
| Debt / Equity | 1.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.30 |
Financial Efficiency
Return on equity (ROE) is -1,109.10% and return on invested capital (ROIC) is -71.07%.
| Return on Equity (ROE) | -1,109.10% |
| Return on Assets (ROA) | -78.30% |
| Return on Capital (ROIC) | -71.07% |
| Revenue Per Employee | $272,231 |
| Profits Per Employee | -$2.27M |
| Employee Count | 52 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +204.58% in the last 52 weeks. The beta is 0.39, so TSHA's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +204.58% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 2.32 |
| Relative Strength Index (RSI) | 37.74 |
| Average Volume (20 Days) | 3,859,738 |
Short Selling Information
The latest short interest is 13.45 million, so 6.68% of the outstanding shares have been sold short.
| Short Interest | 13.45M |
| Short Previous Month | 14.72M |
| Short % of Shares Out | 6.68% |
| Short % of Float | 12.18% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
In the last 12 months, TSHA had revenue of $14.16 million and -$118.01 million in losses. Loss per share was -$0.49.
| Revenue | 14.16M |
| Gross Profit | 14.16M |
| Operating Income | -80.21M |
| Pretax Income | -118.01M |
| Net Income | -118.01M |
| EBITDA | -111.78M |
| EBIT | -114.35M |
| Loss Per Share | -$0.49 |
Balance Sheet
The company has $126.58 million in cash and $59.01 million in debt, giving a net cash position of $67.57 million or $0.34 per share.
| Cash & Cash Equivalents | 126.58M |
| Total Debt | 59.01M |
| Net Cash | 67.57M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 53.85M |
| Book Value Per Share | 0.27 |
| Working Capital | 91.96M |
Cash Flow
In the last 12 months, operating cash flow was -$72.63 million and capital expenditures -$109,000, giving a free cash flow of -$72.74 million.
| Operating Cash Flow | -72.63M |
| Capital Expenditures | -109,000 |
| Free Cash Flow | -72.74M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 100.00%, with operating and profit margins of -566.61% and -833.60%.
| Gross Margin | 100.00% |
| Operating Margin | -566.61% |
| Pretax Margin | -833.60% |
| Profit Margin | -833.60% |
| EBITDA Margin | -789.63% |
| EBIT Margin | -807.80% |
| FCF Margin | -513.85% |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -265.55% |
| Shareholder Yield | -265.55% |
| Earnings Yield | -27.38% |
| FCF Yield | -16.88% |
Analyst Forecast
The average price target for TSHA is $6.60, which is 208.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.60 |
| Price Target Difference | 208.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 58.83% |
| EPS Growth Forecast (5Y) | -20.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of -3.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.96 |
| Piotroski F-Score | 3 |